MT-TP and metabolic dysfunction-associated steatotic liver disease: Furthermore, we found that the mutation rate of MTTP rs2306986 (c.294G>C, p.E98D) and SLC6A2 rs3743788 (c.1646T>C,p.I549T) was significantly higher in subjects with NAFLD than that without NAFLD.